Access to quality cancer care to be addressed at statewide session
Fort Myers, Fla., April 15, 2021 – Physicians and leaders of Florida Cancer Specialists & Research Institute (FCS) are participating in the Florida Society of Clinical Oncology (FLASCO) 2021 Business of Oncology Summit & Spring Session being held in Kissimmee, FL on April 16 & 17. The two-day statewide gathering of oncology physicians, clinicians and support staff will focus on strategies to resolve barriers that hinder access to cancer care.
FCS Assistant Managing Physician Michael Diaz, MD will moderate the Legislative & Regulatory Insights session, which will also feature FCS medical oncologist Paresh Patel, MD as a panelist. Dr. Diaz is a past President of FLASCO and currently serves as Director of Advocacy and Federal Legislative Committee Chair. Dr. Patel serves as FLASCO Legislative Committee Chair.
Also serving as session panelists are:
- FCS medical oncologist Wynn Sullivan, DO – Social Determinants of Health & Implications for Cancer
- FCS medical oncologist Maen Hussein, MD – Information Conundrum
- FCS Associate Director of Patient Financial Services Rhett Wilkerson – Medicare Advantage and Patient Access to Care: A Growing Dilemma
“Florida Cancer Specialists is proud of our continued collaboration with fellow industry leaders to develop key strategies for the evolving future of cancer care,” said FCS CEO Nathan H. Walcker.
FCS President & Managing Physician Dr. Lucio Gordan added, “Our oncologists, allied health professionals and senior leaders will share and gain valuable perspectives and insights. By doing so, we will further strengthen FCS initiatives to maintain access to quality care for our patients.”
The Florida Society of Clinical Oncology (FLASCO) is a statewide non-profit organization committed to facilitating and promoting multidisciplinary efforts for oncology practitioners and industry professionals to improve patient care in Florida.
About Florida Cancer Specialists & Research Institute
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past 5 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, MD Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies, and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians, and staff.
*Prior to approval
For More Information, Contact:
Michelle Robey, Vice President of Marketing
Maryalice Keller, Corporate Communications Manager